國立高雄大學圖資館 |

Language: English

Back

Systems pharmacology and pharmacodyn...

Kimko, Holly H.C.

Systems pharmacology and pharmacodynamics

Record Type:	Electronic resources : Monograph/item
Title/Author:	Systems pharmacology and pharmacodynamicsedited by Donald E. Mager, Holly H.C. Kimko.
other author:	Mager, Donald E.
Published:	Cham :Springer International Publishing :2016.
Description:	xiii, 511 p. :ill., digital ;24 cm.
Contained By:	Springer eBooks
Subject:	Pharmacology.
Online resource:	http://dx.doi.org/10.1007/978-3-319-44534-2
ISBN:	9783319445342$q(electronic bk.)

Systems pharmacology and pharmacodynamics
Systems pharmacology and pharmacodynamics[electronic resource] /edited by Donald E. Mager, Holly H.C. Kimko. - Cham :Springer International Publishing :2016. - xiii, 511 p. :ill., digital ;24 cm. - AAPS advances in the pharmaceutical sciences series,v.232210-7371 ;. - AAPS advances in the pharmaceutical sciences series ;3..

Role of Systems Modeling in Regulatory Drug Approval -- Quantitative Systems Pharmacology: Applications and Adoption in Drug Development -- Systems Pharmacology: An Overview -- Discrete dynamic modeling: a network approach for systems pharmacology -- Kinetic Models of Biochemical Signaling Networks -- Mechanistic Models of Physiological Control Systems -- Foundations of Pharmacodynamic Systems Analysis -- Direct, Indirect, and Signal Transduction Response Modeling -- Irreversible Pharmacodynamics -- Feedback Control Indirect Response Models -- Nonlinear Mixed Effects Modeling in Systems Pharmacology -- Detecting Pharmacokinetic and Pharmacodynamic Covariates From High-Dimensional Data -- Multi-Scale Modeling of Drug Action in the Nervous System -- Mechanistic Modeling of Inflammation -- Systems Pharmacology of Tyrosine Kinase Inhibitor-Associated Toxicities -- Translational Modeling of Antibacterial Agents -- Viral Dynamic Modeling of Hepatitis C Virus Infection: Past Successes and Future Challenges -- Using Systems Pharmacology to Advance Oncology Drug Development -- Systems Pharmacology Modeling in Type 2 Diabetes Mellitus.

While systems biology and pharmacodynamics have evolved in parallel, there are significant interrelationships that can enhance drug discovery and enable optimized therapy for each patient. Systems pharmacology is the relatively new discipline that is the interface between these two methods. This book is the first to cover the expertise from systems biology and pharmacodynamics researchers, describing how systems pharmacology may be developed and refined further to show practical applications in drug development. There is a growing awareness that pharmaceutical companies should reduce the high attrition in the pipeline due to insufficient efficacy or toxicity found in proof-of-concept and/or Phase II studies. Systems Pharmacology and Pharmacodynamics discusses the framework for integrating information obtained from understanding physiological/pathological pathways (normal body function system vs. perturbed system due to disease) and pharmacological targets in order to predict clinical efficacy and adverse events through iterations between mathematical modeling and experimentation.

ISBN: 9783319445342$q(electronic bk.)

Standard No.: 10.1007/978-3-319-44534-2doiSubjects--Topical Terms:

218135
Pharmacology.

LC Class. No.: RM300

Dewey Class. No.: 615.1

Systems pharmacology and pharmacodynamics
LDR:03274nmm a2200325 a 4500 001 500896
003 DE-He213
005 20161201061725.0
006 m d
007 cr nn 008maaau
008 170718s2016 gw s 0 eng d
020 $a 9783319445342$q(electronic bk.)
020 $a 9783319445328$q(paper)
024 7 $a 10.1007/978-3-319-44534-2 $2 doi
035 $a 978-3-319-44534-2
040 $a GP $c GP
041 0 $a eng
050 4 $a RM300
072 7 $a TDCW $2 bicssc
072 7 $a MED072000 $2 bisacsh
082 0 4 $a 615.1 $2 23
090 $a RM300 $b .S995 2016
245 0 0 $a Systems pharmacology and pharmacodynamics $h [electronic resource] / $c edited by Donald E. Mager, Holly H.C. Kimko.
260 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2016.
300 $a xiii, 511 p. : $b ill., digital ; $c 24 cm.
490 1 $a AAPS advances in the pharmaceutical sciences series, $x 2210-7371 ; $v v.23
505 0 $a Role of Systems Modeling in Regulatory Drug Approval -- Quantitative Systems Pharmacology: Applications and Adoption in Drug Development -- Systems Pharmacology: An Overview -- Discrete dynamic modeling: a network approach for systems pharmacology -- Kinetic Models of Biochemical Signaling Networks -- Mechanistic Models of Physiological Control Systems -- Foundations of Pharmacodynamic Systems Analysis -- Direct, Indirect, and Signal Transduction Response Modeling -- Irreversible Pharmacodynamics -- Feedback Control Indirect Response Models -- Nonlinear Mixed Effects Modeling in Systems Pharmacology -- Detecting Pharmacokinetic and Pharmacodynamic Covariates From High-Dimensional Data -- Multi-Scale Modeling of Drug Action in the Nervous System -- Mechanistic Modeling of Inflammation -- Systems Pharmacology of Tyrosine Kinase Inhibitor-Associated Toxicities -- Translational Modeling of Antibacterial Agents -- Viral Dynamic Modeling of Hepatitis C Virus Infection: Past Successes and Future Challenges -- Using Systems Pharmacology to Advance Oncology Drug Development -- Systems Pharmacology Modeling in Type 2 Diabetes Mellitus.
520 $a While systems biology and pharmacodynamics have evolved in parallel, there are significant interrelationships that can enhance drug discovery and enable optimized therapy for each patient. Systems pharmacology is the relatively new discipline that is the interface between these two methods. This book is the first to cover the expertise from systems biology and pharmacodynamics researchers, describing how systems pharmacology may be developed and refined further to show practical applications in drug development. There is a growing awareness that pharmaceutical companies should reduce the high attrition in the pipeline due to insufficient efficacy or toxicity found in proof-of-concept and/or Phase II studies. Systems Pharmacology and Pharmacodynamics discusses the framework for integrating information obtained from understanding physiological/pathological pathways (normal body function system vs. perturbed system due to disease) and pharmacological targets in order to predict clinical efficacy and adverse events through iterations between mathematical modeling and experimentation.
650 0 $a Pharmacology. $3 218135
650 0 $a Pharmacokinetics. $3 190329
650 0 $a Systems biology. $3 282663
650 1 4 $a Biomedicine. $3 273648
650 2 4 $a Pharmaceutical Sciences/Technology. $3 338426
650 2 4 $a Mathematical and Computational Biology. $3 514442
650 2 4 $a Medical Biochemistry. $3 274286
700 1 $a Mager, Donald E. $3 764145
700 1 $a Kimko, Holly H.C. $3 764146
710 2 $a SpringerLink (Online service) $3 273601
773 0 $t Springer eBooks
830 0 $a AAPS advances in the pharmaceutical sciences series ; $v 3. $3 559046
856 4 0 $u http://dx.doi.org/10.1007/978-3-319-44534-2
950 $a Biomedical and Life Sciences (Springer-11642)